1. Introduction {#sec1}
===============

Single nucleotide polymorphism (SNP) is a variation at a single nucleotide in a DNA sequence \[[@B1]\]. In the last decade, a large number of genome-wide association studies (GWAS) have been published, indicating that thousands of SNPs are associated with diseases. Linkage disequilibrium is the nonrandom association of alleles at different genome locations \[[@B2]\]. There are many SNPs in LD with the causal SNP at specific GWAS locus \[[@B3], [@B4]\]. Over 90% of these GWAS variants are located in noncoding regions, and approximately 10% are in LD with a protein-coding variant \[[@B5], [@B6]\]. In protein-coding regions, many studies have shown that some SNPs are associated with numerous diseases by affecting gene expression \[[@B7], [@B8]\]. However, in noncoding regions, the mechanism of how SNPs contribute to disease susceptibility remains unclear.

Enhancers are the core regulatory components of the genome that act over a distance to positively regulate gene expression \[[@B9]\]. It is estimated that 400,000 to 1 million putative enhancers exist in the human genome \[[@B10], [@B11]\]. Recently, some studies have shown that disease-related GWAS SNPs are correlated with enhancers marked with special histone modifications \[[@B12]--[@B15]\]. Therefore, through integrating GWAS and histone modification ChIP-seq data in a given disorder, we can identify disease-related enhancer SNPs.

We provided a method for identifying liver cancer-related enhancer SNPs through integrating liver cancer GWAS and histone modification ChIP-seq data. We identified 22 enhancer SNPs associated with liver cancer, 9 of which were regulatory SNPs involved in distal transcriptional regulation. The results highlight that these enhancer SNPs may play important roles in liver cancer.

2. Results {#sec2}
==========

2.1. Pipeline of Identifying Liver Cancer-Related Enhancer SNPs {#sec2.1}
---------------------------------------------------------------

As shown in [Figure 1](#fig1){ref-type="fig"}, the pipeline consists of four steps. Firstly, we downloaded liver cancer-related GWAS SNPs from the GRASP \[[@B16]\] database and used LD data from HapMap \[[@B17]\] to infer liver cancer-related LD SNPs. Secondly, we identified enhancer regions in liver cancer through integrating histone modification ChIP-seq data in the HepG2 cell line. Thirdly, we mapped the liver cancer-related LD SNPs to the identified enhancers in liver cancer and obtained liver cancer-related enhancer SNPs. Finally, we used a curated regulatory SNP database named rVarBase \[[@B18]\] to validate our results.

2.2. Linkage Disequilibrium Analysis with Liver Cancer-Associated SNPs {#sec2.2}
----------------------------------------------------------------------

We obtained 45 liver cancer-associated SNPs from GRASP ([Table 1](#tab1){ref-type="table"}). These SNPs are the raw potential liver cancer-related SNPs. Then, we used LD data from HapMap to achieve liver cancer-associated LD SNPs. The total number of potential liver cancer-related SNPs is 340.

2.3. Identification of Liver Cancer-Related Enhancer SNPs {#sec2.3}
---------------------------------------------------------

Previous studies indicated that the enhancer regions are marked by a strong H3K4me1 signal and a relatively weak H3K4me3 signal \[[@B19], [@B20]\]. Thus, we used histone modification ChIP-seq data to recognize the enhancer regions in liver cancer. Then, we mapped the liver cancer-related GWAS SNPs to the enhancer regions and obtained 22 enhancer SNPs in liver cancer ([Table 2](#tab2){ref-type="table"}).

2.4. Validation as Regulatory SNPs {#sec2.4}
----------------------------------

rVarBase is a database that provides reliable, comprehensive, and user-friendly annotations on variant\'s regulatory features \[[@B18]\]. It includes regulatory SNPs (rSNPs), LD-proxies of rSNPs, and genes that are potentially regulated by rSNPs. We used rVarBase to analyze these 22 enhancer SNPs in liver cancer and found that 14 SNPs have evidence of regulatory SNPs and 9 SNPs (rs9494257, rs6903949, rs6996881, rs4739519, rs6988263, rs12156293, rs1568658, rs5994449, and rs5753816) are involved in distal transcriptional regulation ([Table 3](#tab3){ref-type="table"}). [Table 4](#tab4){ref-type="table"} shows the potential target genes of these 9 SNPs.

3. Materials and Methods {#sec3}
========================

3.1. GWAS and LD Datasets {#sec3.1}
-------------------------

We downloaded the human liver cancer-related GWAS SNPs from GRASP. The database includes 26 and 19 liver cancer-associated SNPs (*p* \< 10^−5^) from Han Chinese in Beijing, China (CHB), and Japanese in Tokyo, Japan (JPT), respectively. The URL is <https://grasp.nhlbi.nih.gov/Overview.aspx>. We obtained all SNPs in LD with GWAS-lead SNPs using LD blocks identified with publicly available HapMap data on the CHB and JPT populations. The LD data can be downloaded from <http://hapmap.ncbi.nlm.nih.gov/index.html/>.

3.2. Histone Modification Datasets {#sec3.2}
----------------------------------

We downloaded the human histone modification ChIP-seq datasets in the HepG2 cell line from the ENCODE Production Data/Broad Institute. The URL is <http://genome.ucsc.edu/ENCODE/downloads.html>.

3.3. Linkage Disequilibrium Analysis {#sec3.3}
------------------------------------

In the genome, SNPs located in close proximity tend to be in linkage disequilibrium with each other. The International HapMap Project has established linkage disequilibrium of human genome SNPs. We used LD data from HapMap to achieve liver cancer-associated LD SNPs (*R* ^2^ \> 0.8).

3.4. Identify Enhancer Regions and Enhancer SNPs {#sec3.4}
------------------------------------------------

Firstly, we downloaded the human histone modification BAM files (H3K4me1 and H3K4me3) in the HepG2 cell line from the ENCODE project. Then, we used BEDtools \[[@B21]\] to count read coverage for every position of the genome. Through calculating the ratio H3K4me1/H3K4me3 and picking up the regions with log~2~(H3K4me1/H3K4me3) \> 1.2, we identified the potential enhancer regions. Finally, we mapped the potential LD SNPs to these enhancer regions and achieved liver cancer-related enhancer SNPs.

4. Discussion {#sec4}
=============

Through integrating liver cancer GWAS SNPs from GRASP, LD data from HapMap, and histone modification ChIP-seq data from ENCODE, we explored liver cancer-related enhancer SNPs. We compared our results with rVarBase and found that 9 SNPs (rs9494257, rs6903949, rs6996881, rs4739519, rs6988263, rs12156293, rs1568658, rs5994449, and rs5753816) were regulatory SNPs involved in distal transcriptional regulation. The results highlight that these enhancer SNPs may play important roles in liver cancer.

Compared with protein-coding regions in the human genome, noncoding regions contain much more genetic variations. Some important regulation regions, such as enhancers, have great influence on target gene expression. SNPs located in these regions may disturb gene expression and even cause diseases. Thus, the identification of SNPs in enhancer regions is helpful to understand the mechanism of association between SNPs and diseases.

We presented a method to identify disease-related SNPs located in enhancer regions that gives a new solution to investigate the relationship between SNPs and diseases. The presented method can also be applied to other diseases and will enable biologists to investigate the mechanism of disease risk associated with SNPs.
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###### 

Summary of liver cancer-associated SNPs from GRASP database.

  SNP ID       *p* value      Chromosome   Populations   PMID
  ------------ -------------- ------------ ------------- ----------
  rs17401966   1.20*E* − 19   1            CHB           20676096
  rs1249458    8.30*E* − 06   2            CHB           22807686
  rs1714259    1.10*E* − 06   2            CHB           22807686
  rs2396470    5.10*E* − 07   2            CHB           20676096
  rs7424161    8.80*E* − 06   2            CHB           22807686
  rs7574865    1.70*E* − 11   2            CHB           23242368
  rs3905886    3.70*E* − 06   3            CHB           22807686
  rs1073547    6.80*E* − 06   4            CHB           22807686
  rs17081345   3.70*E* − 07   6            CHB           20676096
  rs9272105    3.30*E* − 23   6            CHB           22807686
  rs9275319    8.70*E* − 19   6            CHB           23242368
  rs9494257    1.10*E* − 14   6            CHB           20676096
  rs12682266   6.70*E* − 06   8            CHB           22174901
  rs1573266    7.40*E* − 06   8            CHB           22174901
  rs2275959    6.40*E* − 06   8            CHB           22174901
  rs7821974    7.00*E* − 06   8            CHB           22174901
  rs7898005    7.00*E* − 08   10           CHB           20676096
  rs10160758   6.00*E* − 06   11           CHB           22807686
  rs10896464   6.50*E* − 06   11           CHB           22807686
  rs2611145    9.30*E* − 06   11           CHB           22174901
  rs3825023    3.10*E* − 06   11           CHB           22807686
  rs7119426    3.50*E* − 06   11           CHB           22807686
  rs402071     8.60*E* − 06   19           CHB           22807686
  rs3092194    4.40*E* − 06   20           CHB           22807686
  rs368007     9.90*E* − 06   20           CHB           22807686
  rs455804     4.40*E* − 10   21           CHB           22807686
  rs1980215    2.30*E* − 06   3            JPT           21499248
  rs2596542    4.20*E* − 13   6            JPT           21499248
  rs9275572    1.40*E* − 09   6            JPT           21499248
  rs1568658    6.90*E* − 06   7            JPT           21499248
  rs952656     2.80*E* − 06   8            JPT           21499248
  rs4363614    4.20*E* − 07   11           JPT           21499248
  rs1957496    4.60*E* − 06   14           JPT           21499248
  rs8019534    3.90*E* − 06   14           JPT           21499248
  rs1794304    3.60*E* − 06   16           JPT           21725309
  rs2208456    3.80*E* − 06   20           JPT           21499248
  rs1012068    1.30*E* − 14   22           JPT           21725309
  rs11703779   4.20*E* − 06   22           JPT           21725309
  rs4820994    3.00*E* − 06   22           JPT           21725309
  rs4820996    4.20*E* − 06   22           JPT           21725309
  rs5753816    4.90*E* − 06   22           JPT           21725309
  rs5753818    9.40*E* − 06   22           JPT           21725309
  rs5998152    1.20*E* − 07   22           JPT           21725309
  rs7287054    3.80*E* − 06   22           JPT           21725309
  rs737084     5.90*E* − 06   22           JPT           21725309

###### 

Summary of predicted enhancer SNPs in liver cancer.

  SNP ID       Chromosome   Start       End         Chain   Populations
  ------------ ------------ ----------- ----------- ------- -------------
  rs12751375   chr1         10291873    10291874    \+      CHB
  rs6700866    chr1         10306037    10306038    \+      CHB
  rs9494257    chr6         135827471   135827472   \+      CHB
  rs17064474   chr6         135680137   135680138   \+      CHB
  rs17721919   chr6         135748923   135748924   \+      CHB
  rs17721931   chr6         135749377   135749378   \+      CHB
  rs6903949    chr6         135821065   135821066   \+      CHB
  rs6996881    chr8         37407919    37407920    \+      CHB
  rs4739519    chr8         37412858    37412859    \+      CHB
  rs6988263    chr8         37414659    37414660    \+      CHB
  rs12156293   chr8         37419921    37419922    \+      CHB
  rs6928810    chr6         31410523    31410524    \+      JPT
  rs3869132    chr6         31410947    31410948    −       JPT
  rs2596562    chr6         31354594    31354595    −       JPT
  rs2523475    chr6         31361709    31361710    −       JPT
  rs2523467    chr6         31362929    31362930    −       JPT
  rs9501387    chr6         31364458    31364459    \+      JPT
  rs1568658    chr7         29141557    29141558    −       JPT
  rs1794304    chr16        12625394    12625395    \+      JPT
  rs5994449    chr22        32304178    32304179    \+      JPT
  rs5753816    chr22        32312841    32312842    \+      JPT
  rs5749339    chr22        32315734    32315735    \+      JPT

###### 

Summary of liver cancer-related regulatory SNPs validated by rVarBase.

  SNP ID       Regulatory SNP   Distal regulation   Chromatin state                                                                          Related regulatory elements
  ------------ ---------------- ------------------- ---------------------------------------------------------------------------------------- -------------------------------------------------
  rs12751375   Yes              No                  Inactive region                                                                          n/a
  rs6700866    Yes              No                  Weak transcription; ZNF genes and repeats; strong transcription; enhancers               n/a
  rs9494257    Yes              Yes                 Enhancers; flanking active TSS; weak transcription                                       Chromatin interactive region
  rs17064474   Yes              No                  Weak transcription; active TSS; flanking active TSS; enhancers                           n/a
  rs17721919   Yes              No                  Weak transcription                                                                       n/a
  rs17721931   Yes              No                  Weak transcription                                                                       n/a
  rs6903949    Yes              Yes                 Weak transcription; enhancers                                                            TF binding region; chromatin interactive region
  rs6996881    Yes              Yes                 Weak transcription; enhancers                                                            Chromatin interactive region
  rs4739519    Yes              Yes                 Enhancers; weak transcription                                                            Chromatin interactive region
  rs6988263    Yes              Yes                 Enhancers; weak transcription; genic enhancers; bivalent enhancer; flanking active TSS   Chromatin interactive region
  rs12156293   Yes              Yes                 Enhancers; weak transcription; bivalent enhancer; genic enhancers                        Chromatin interactive region
  rs1568658    Yes              Yes                 Weak transcription; enhancers; strong transcription                                      Chromatin interactive region
  rs5994449    Yes              Yes                 Weak transcription; strong transcription; ZNF genes and repeats                          Chromatin interactive region
  rs5753816    Yes              Yes                 Weak transcription; enhancers; flanking active TSS                                       Chromatin interactive region

###### 

Summary of liver cancer-related regulatory SNPs and potential target genes validated by rVarBase.

  SNP ID       Gene symbol   Ensemble ID       Regulation type
  ------------ ------------- ----------------- -----------------------------------
  rs9494257    BCLAF1        ENSG00000029363   Distal transcriptional regulation
  rs9494257    AHI1          ENSG00000135541   Distal transcriptional regulation
  rs9494257    LINC00271     ENSG00000231028   Distal transcriptional regulation
  rs6903949    MYB           ENSG00000118513   Distal transcriptional regulation
  rs6903949    BCLAF1        ENSG00000029363   Distal transcriptional regulation
  rs6903949    AHI1          ENSG00000135541   Distal transcriptional regulation
  rs6903949    LINC00271     ENSG00000231028   Distal transcriptional regulation
  rs6996881    ZNF703        ENSG00000183779   Distal transcriptional regulation
  rs6996881    ERLIN2        ENSG00000147475   Distal transcriptional regulation
  rs6996881    Null          ENSG00000183154   Distal transcriptional regulation
  rs6996881    Null          ENSG00000253161   Distal transcriptional regulation
  rs4739519    ZNF703        ENSG00000183779   Distal transcriptional regulation
  rs4739519    Null          ENSG00000254290   Distal transcriptional regulation
  rs6988263    ZNF703        ENSG00000183779   Distal transcriptional regulation
  rs6988263    Null          ENSG00000254290   Distal transcriptional regulation
  rs12156293   ZNF703        ENSG00000183779   Distal transcriptional regulation
  rs12156293   Null          ENSG00000254290   Distal transcriptional regulation
  rs12156293   ERLIN2        ENSG00000147475   Distal transcriptional regulation
  rs12156293   Null          ENSG00000183154   Distal transcriptional regulation
  rs1568658    Null          ENSG00000228421   Distal transcriptional regulation
  rs1568658    TRIL          ENSG00000176734   Distal transcriptional regulation
  rs1568658    Null          ENSG00000255690   Distal transcriptional regulation
  rs5994449    DEPDC5        ENSG00000100150   Distal transcriptional regulation
  rs5994449    FBXO7         ENSG00000100225   Distal transcriptional regulation
  rs5994449    SYN3          ENSG00000185666   Distal transcriptional regulation
  rs5994449    PRR14L        ENSG00000183530   Distal transcriptional regulation
  rs5994449    PISD          ENSG00000241878   Distal transcriptional regulation
  rs5994449    EIF4ENIF1     ENSG00000184708   Distal transcriptional regulation
  rs5994449    RNU6-28       ENSG00000199248   Distal transcriptional regulation
  rs5994449    SFI1          ENSG00000198089   Distal transcriptional regulation
  rs5753816    YWHAH         ENSG00000128245   Distal transcriptional regulation
  rs5753816    C22orf24      ENSG00000128254   Distal transcriptional regulation
  rs5753816    PISD          ENSG00000241878   Distal transcriptional regulation
  rs5753816    DEPDC5        ENSG00000100150   Distal transcriptional regulation
  rs5753816    RNU6-28       ENSG00000199248   Distal transcriptional regulation
  rs5753816    SFI1          ENSG00000198089   Distal transcriptional regulation
  rs5753816    EIF4ENIF1     ENSG00000184708   Distal transcriptional regulation
  rs5753816    RFPL3S        ENSG00000205853   Distal transcriptional regulation
  rs5753816    Null          ENSG00000230736   Distal transcriptional regulation
  rs5753816    Null          ENSG00000243519   Distal transcriptional regulation
  rs5753816    Null          ENSG00000241954   Distal transcriptional regulation
  rs5753816    Null          ENSG00000232218   Distal transcriptional regulation
  rs5753816    SYN3          ENSG00000185666   Distal transcriptional regulation
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